About Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET
During the past decade, Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2015-06-24
2018-01-31
Terminated
296
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
2018-09-05
2021-09-03
Completed
940
A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
2021-03-19
2023-02-10
Completed
665
A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
2021-08-30
2023-02-10
Terminated
117
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET
According to Clinical.Site data, the most researched conditions in "Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET" are
"Idiopathic Pulmonary Fibrosis" (2 trials), "Diabetic Macular Edema" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET" in a lesser frequency.
Clinical Trials Intervention Types at Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET
Most popular intervention types in "Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET" are "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Aflibercept" (1 trials), "Faricimab" (1 trials), "No intervention" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET
The vast majority of trials in "Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET" are
4 trials for "All" genders.
Clinical Trials Status at Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET
Currently, there are NaN active trials in "Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".